Jayson Rieger
InvestorManaging Partner at PBM Capital · Board director at Verrica Pharmaceuticals
Greater Boston
Find your path to Jayson
819 people in our graph share verified history with Jayson — schools, employers, funds. One of them is your warm intro.
About
Jayson Rieger is President and CEO of Verrica Pharmaceuticals, with experience spanning drug discovery, R&D operations, and business development. He has led teams through drug discovery and development programs involving in-house resources, CROs/CMOs, and academic and corporate partnerships, and has been the principal executive in M&A, IPO, and capital-raising transactions. He has authored or co-authored more than thirty peer-reviewed publications, is a co-inventor on more than thirty-five issued or pending patents, and has served as principal or co-investigator on over ten NIH grants totaling more than $20 million in research funding.
Board director at Verrica Pharmaceuticals
Intro paths
In turn, Jayson can intro founders to Verrica Pharmaceuticals's investors below.
Verrica Pharmaceuticals's investors · 1
Experience
- Verrica PharmaceuticalsCEO and Presidentcurrent2024 — present
- PBM Capital GroupExecutive Vice President2014 — 2024
- Pavilion XI Partners, LLCPresident2013 — 2014
- Intrexon CorporationPresident, Human Therapeutics Division (HTD), Corporate Senior Vice-President2012 — 2013Germantown, MD
- Forest LaboratoriesVice President, Research and Virginia Operations2011 — 2012Greater Charlottesville Area
- Clinical DataVice President, Research and Virginia Operations2008 — 2011Greater Charlottesville Area
- Adenosine Therapeutics, LLCVice President, Lead Development2002 — 2008Greater Charlottesville Area
Skills & more
+12 more
Drug DevelopmentChemistryProject ManagementTechnology TransferCommercializationLifesciencesClinical TrialsMedicinal ChemistryClinical DevelopmentProduct DevelopmentFDAPharmacologyFrom Jayson's professional profile.
Deals · 2
Xalud Therapeutics, Inc.Board seat
via PBM Capital · filed Jun 2021 · $30M raise
Verrica PharmaceuticalsBoard seat
via PBM Capital · filed Dec 2015
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at PBM Capital
Frequently asked questions
- Who is Jayson Rieger?
- Jayson Rieger is President and CEO of Verrica Pharmaceuticals, with experience spanning drug discovery, R&D operations, and business development. He has led teams through drug discovery and development programs involving in-house resources, CROs/CMOs, and academic and corporate partnerships, and has been the principal executive in M&A, IPO, and capital-raising transactions. He has authored or co-authored more than thirty peer-reviewed publications, is a co-inventor on more than thirty-five issued or pending patents, and has served as principal or co-investigator on over ten NIH grants totaling more than $20 million in research funding.
- Where does Jayson Rieger work?
- Jayson Rieger is Managing Partner at PBM Capital and Board director at Verrica Pharmaceuticals.
- What boards does Jayson Rieger sit on?
- Jayson Rieger holds tracked board seats at Verrica Pharmaceuticals, Xalud Therapeutics, Inc..
- Where did Jayson Rieger go to school?
- Jayson Rieger studied at University of Virginia Darden School of Business (MBA, Business Administration and Management); University of Virginia (Ph.D., Medicinal Chemistry); Rollins College (B.A., Chemistry).
Founder mafias
University of Virginia mafia190
Also came through, then founded or led a company.
+ 183 more
University of Virginia Darden School of Business mafia36
Also came through, then founded or led a company.
+ 29 more
Rollins College mafia9
Also came through, then founded or led a company.
+ 2 more
Same school
Also attended University of Virginia Darden School of Business169
+ 163 more
Also attended University of Virginia661
+ 655 more
Also attended Rollins College16
+ 10 more
Shared employers
Also worked at PBM Capital Group2
Also worked at Intrexon Corporation9
+ 3 more
Also worked at Forest Laboratories9
+ 3 more















































